Watch Mary Hesdorffer, the Meso Foundation’s executive director and mesothelioma expert, in this opening presentation at the 2015 International Symposium on Malignant Mesothelioma. In this video, she discusses the state of mesothelioma research and treatment options. Her discussion begins with a focus on clinical trials. With 92 open clinical trials for mesothelioma, of which 55 […]
mesothelioma clinical trials
by Lee Krug, MD, Memorial Sloan Kettering Cancer Center
This month, a notification was sent to investigators on the DETERMINE Trial that accrual will be completed by the end of October. DETERMINE is an international, randomized trial comparing treatment with an immunotherapy drug called tremelimumab to treatment with placebo as second or third line therapy in […]
The content from the Meso Foundation’s regional conference, presented as a collaboration between the Mesothelioma Applied Research Foundation and Penn’s Abramson Cancer Center, held in Philadelphia on September 26, 2014, is now available for viewing online on the Abramson Cancer Center website.
The conference featured area experts in the field of mesothelioma.
All sessions are now available online […]
On September 10, the Meso Foundation will interview Stephen Isaacs, the chairperson, president, and CEO of Adura BioTech, during a new installment of the Foundation’s Meet the Mesothelioma Experts live broadcast. The interview will be led by the Meso Foundation’s executive director and mesothelioma expert nurse practitioner, Mary Hesdorffer, APRN.
The focus of the interview will […]
During the July 2014 board meeting of the Mesothelioma Applied Research Foundation, mesothelioma expert and executive director of the Meso Foundation, Mary Hesdorffer, APRN, stated that mesothelioma patients today have more promising clinical trials to choose from than ever before.
In her talk, she mentioned several trials that have been reporting increased survival and response rates. Some include […]